Live Breaking News & Updates on Symptomatic Skeletal Event

Stay updated with breaking news from Symptomatic skeletal event. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Astellas Announces Phase 3 China ARCHES Study of XTANDI® Meets Primary Endpoint

/PRNewswire/ Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") today announced positive topline results from the Phase. ....

United States , Kenji Yasukawa , Ahsan Arozullah , Zhou Fangjian , American Society Of Clinical Oncology , Sun Yat Sen University Cancer Center , China National Medical Products Administration , Astellas Pharma Inc , Fudan University Shanghai Cancer Center , Head Of Development Therapeutic Areas , Head Of Urology Department , Sun Yat Sen University , Medivation Inc , Astellas Pharma , Senior Vice President , Development Therapeutic Areas , Urology Department , Sun Yat Sen , Vice President , Multi Disciplinary Team , Symptomatic Skeletal Event , Important Safety Information , Focus Area Approach , American Society , Prostate Cancer , Accessed September ,